Skip to content
HowShorted

The Macerich Company short interest in 2021

In 2021, The Macerich Company's disclosed short interest ran from 52.55% of shares outstanding on 15 Jan 2021 to 12.41% on 31 Dec 2021, a change of -40.14 percentage points. The year's high was 52.55% on 15 Jan 2021 and its low 10.41% on 15 Jul 2021, averaging 16.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.92 days on 15 Jan 2021. Full history: The Macerich Company.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for The Macerich Company in 2021

2021 in figures

Start of year
52.55% (15 Jan 2021)
End of year
12.41% (31 Dec 2021)
Change
-40.14 pp
High
52.55% (15 Jan 2021)
Low
10.41% (15 Jul 2021)
Average
16.44%
Highest days to cover
17.92 (15 Jan 2021)
SEC filings marked
9

Every report in 2021

The Macerich Company short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202152.55%17.92
29 Jan 202122.95%2.18
12 Feb 202124.14%3.31results (8-K), results (8-K)
26 Feb 202123.32%4.9210-K filed
15 Mar 202123.00%4.55
31 Mar 202120.71%3.55
15 Apr 202119.78%8.83
30 Apr 202115.40%5.27
14 May 202111.81%5.6810-Q filed, results (8-K)
28 May 202111.53%4.72
15 Jun 202112.58%4.92
30 Jun 202111.57%3.46
15 Jul 202110.41%6.01
30 Jul 202110.57%8.64
13 Aug 202111.11%7.73results (8-K), 10-Q filed
31 Aug 202111.14%7.39
15 Sep 202111.73%9.03
30 Sep 202112.29%7.77
15 Oct 202112.95%13.73
29 Oct 202112.89%11.98
15 Nov 202113.55%7.49results (8-K), 10-Q filed
30 Nov 202113.62%12.86
15 Dec 202112.56%8.62
31 Dec 202112.41%9.49

See also: The Macerich Company's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.